CAAS Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,534
Closed -$49K 672
2022
Q2
$49K Buy
+11,534
New +$49K ﹤0.01% 381